Skip to main content
Top
Published in: Reproductive Medicine and Biology 4/2016

01-10-2016 | Minireview

Predicting suitable timing for artificial reproductive technology treatment in aged infertile women

Authors: Nana Akino, Wataru Isono, Osamu Wada-Hiraike

Published in: Reproductive Medicine and Biology | Issue 4/2016

Login to get access

Abstract

It has been widely accepted that the age of women plays a fundamental role in fecundity, and age-related fertility decline has one of the most significant and detrimental effects on the success rate of infertility treatment. Therefore, treatment cycles of non-in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment for infertile women of advanced aged have been limited due to their lack of efficacy, and they are often optimized, compared to IVF/ICSI treatment. Recent trends in infertility treatment apparently indicate that IVF/ICSI treatment, including egg donation, is frequently offered to aged women for first-line management, despite its heavy burden, but hasty IVF/ICSI treatment should be avoided, considering its socioeconomic problems. It is important to distinguish women who could conceive by non-IVF/ICSI treatment, although the optimization of non-IVF/ICSI treatment protocols remains poorly understood. This review focuses on extracting aged patients who have higher chance of conceiving with non-IVF/ICSI treatment and providing necessary and sufficient infertility treatment. After initial evaluation for fertility, including tubal factor, male factor, the presence of endometriosis and/or adenomyosis, and ovarian reserve, the outcomes of fertility treatment can be predicted to some extent in aged infertile women.
Literature
1.
go back to reference ACOG Committee Opinion. Age-related fertility decline. Obstet Gynecol. 2008;112:409–11.CrossRef ACOG Committee Opinion. Age-related fertility decline. Obstet Gynecol. 2008;112:409–11.CrossRef
2.
go back to reference Dew JE, Don RA, Hughes GJ, Johnson TC, Steigrad SJ. The influence of advanced age on the outcome of assisted reproduction. J Assist Reprod Genet. 1998;15:210–4.CrossRefPubMedPubMedCentral Dew JE, Don RA, Hughes GJ, Johnson TC, Steigrad SJ. The influence of advanced age on the outcome of assisted reproduction. J Assist Reprod Genet. 1998;15:210–4.CrossRefPubMedPubMedCentral
3.
go back to reference Ziebe S, Devroey P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008;14:583–92.CrossRefPubMed Ziebe S, Devroey P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008;14:583–92.CrossRefPubMed
5.
go back to reference Frederick JL, Denker MS, Rojas A, Horta I, Stone SC, Asch RH, Balmaceda JP. Is there a role for ovarian stimulation and intra-uterine insemination after age 40? Hum Reprod. 1994;9:2284–6.PubMed Frederick JL, Denker MS, Rojas A, Horta I, Stone SC, Asch RH, Balmaceda JP. Is there a role for ovarian stimulation and intra-uterine insemination after age 40? Hum Reprod. 1994;9:2284–6.PubMed
6.
go back to reference Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM. One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. Fertil Steril. 1998;70:1030–4.CrossRefPubMed Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM. One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. Fertil Steril. 1998;70:1030–4.CrossRefPubMed
7.
go back to reference Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod Biomed Online. 2007;14:348–55.CrossRefPubMed Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod Biomed Online. 2007;14:348–55.CrossRefPubMed
8.
go back to reference Marinakis G, Nikolaou D. National survey of the current management of infertility in women aged 40 and over in the UK. J Obstet Gynaecol. 2012;32:375–8.CrossRefPubMed Marinakis G, Nikolaou D. National survey of the current management of infertility in women aged 40 and over in the UK. J Obstet Gynaecol. 2012;32:375–8.CrossRefPubMed
9.
go back to reference Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod. 1996;11:1109–12.CrossRefPubMed Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod. 1996;11:1109–12.CrossRefPubMed
11.
go back to reference Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population, Hum Reprod. 2009;24:3127–35. Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population, Hum Reprod. 2009;24:3127–35.
12.
go back to reference Speyer BE, Abramov B, Saab W, Doshi A, Sarna U, Harper JC, Serhal P. Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds. J Obstet Gynaecol. 2013;33:697–700.CrossRefPubMed Speyer BE, Abramov B, Saab W, Doshi A, Sarna U, Harper JC, Serhal P. Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds. J Obstet Gynaecol. 2013;33:697–700.CrossRefPubMed
13.
go back to reference van der Westerlaken LA, Naaktgeboren N, Helmerhorst FM. Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters. J Assist Reprod Genet. 1998;15:359–64.CrossRefPubMedPubMedCentral van der Westerlaken LA, Naaktgeboren N, Helmerhorst FM. Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters. J Assist Reprod Genet. 1998;15:359–64.CrossRefPubMedPubMedCentral
14.
go back to reference Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14:698–703.CrossRefPubMed Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14:698–703.CrossRefPubMed
15.
go back to reference Isono W, Wada-Hiraike O, Shirane A, Fujimoto A, Osuga Y, Yano T, Taketani Y. Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women. Reprod Med Biol. 2011;11:69–72.CrossRef Isono W, Wada-Hiraike O, Shirane A, Fujimoto A, Osuga Y, Yano T, Taketani Y. Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women. Reprod Med Biol. 2011;11:69–72.CrossRef
16.
go back to reference Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril. 2002;78:1088–95.CrossRefPubMed Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril. 2002;78:1088–95.CrossRefPubMed
17.
go back to reference World Health Organization, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction Cambridge University Press, 2010. World Health Organization, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction Cambridge University Press, 2010.
19.
go back to reference Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis, N Engl J Med. 1997;337:217–22. Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis, N Engl J Med. 1997;337:217–22.
20.
go back to reference Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci. 2008;1127:92–100.CrossRefPubMed Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci. 2008;1127:92–100.CrossRefPubMed
21.
go back to reference Buyalos RP, Agarwal SK. Endometriosis-associated infertility. Curr Opin Obstet Gynecol. 2000;12:377–81.CrossRefPubMed Buyalos RP, Agarwal SK. Endometriosis-associated infertility. Curr Opin Obstet Gynecol. 2000;12:377–81.CrossRefPubMed
22.
go back to reference Wu HM, Tzeng CR, Chen CH, Chen PH. Pelvic endometriosis with peritoneal fluid reduces pregnancy rates in women undergoing intrauterine insemination. Taiwan J Obstet Gynecol. 2013;52:512–5.CrossRefPubMed Wu HM, Tzeng CR, Chen CH, Chen PH. Pelvic endometriosis with peritoneal fluid reduces pregnancy rates in women undergoing intrauterine insemination. Taiwan J Obstet Gynecol. 2013;52:512–5.CrossRefPubMed
23.
go back to reference Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24:235–58.CrossRefPubMed Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24:235–58.CrossRefPubMed
24.
25.
go back to reference Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186:409–15.CrossRefPubMed Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186:409–15.CrossRefPubMed
26.
go back to reference Huang JQ, Lathi RB, Lemyre M, Rodriguez HE, Nezhat CH, Nezhat C. Coexistence of endometriosis in women with symptomatic leiomyomas. Fertil Steril. 2010;94:720–3.CrossRefPubMed Huang JQ, Lathi RB, Lemyre M, Rodriguez HE, Nezhat CH, Nezhat C. Coexistence of endometriosis in women with symptomatic leiomyomas. Fertil Steril. 2010;94:720–3.CrossRefPubMed
27.
go back to reference Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagne D, Hugo P, Gosselin D. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81:1513–21.CrossRefPubMed Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagne D, Hugo P, Gosselin D. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81:1513–21.CrossRefPubMed
28.
go back to reference Isono W, Wada-Hiraike O, Osuga Y, Yano T, Taketani Y. Diameter of dominant leiomyoma is a possible determinant to predict coexistent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2012;162:87–90.CrossRefPubMed Isono W, Wada-Hiraike O, Osuga Y, Yano T, Taketani Y. Diameter of dominant leiomyoma is a possible determinant to predict coexistent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2012;162:87–90.CrossRefPubMed
29.
go back to reference La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.CrossRefPubMed La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.CrossRefPubMed
30.
go back to reference Li HWR, Yeung WSB, Lau EYL, Ho PC, Ng EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010;94:2177–81.CrossRefPubMed Li HWR, Yeung WSB, Lau EYL, Ho PC, Ng EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010;94:2177–81.CrossRefPubMed
31.
go back to reference La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603–10.CrossRef La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603–10.CrossRef
32.
go back to reference Plosker SM, Jacobson W, Amato P. Predicting and optimizing success in an intra-uterine insemination programme. Hum Reprod. 1994;9:2014–21.PubMed Plosker SM, Jacobson W, Amato P. Predicting and optimizing success in an intra-uterine insemination programme. Hum Reprod. 1994;9:2014–21.PubMed
33.
go back to reference Dovey S, Sneeringer RM, Penzias AS. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90:2281–6.CrossRefPubMed Dovey S, Sneeringer RM, Penzias AS. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90:2281–6.CrossRefPubMed
34.
go back to reference Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78:29–33.CrossRefPubMed Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78:29–33.CrossRefPubMed
35.
go back to reference Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol. 2005;192:240–6.CrossRefPubMed Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol. 2005;192:240–6.CrossRefPubMed
36.
go back to reference Tsafrir A, Simon A, Margalioth EJ, Laufer N. What should be the first-line treatment for unexplained infertility in women over 40 years of age—ovulation induction and IUI, or IVF? Reprod Biomed Online. 2009;19(Suppl 4):4334.PubMed Tsafrir A, Simon A, Margalioth EJ, Laufer N. What should be the first-line treatment for unexplained infertility in women over 40 years of age—ovulation induction and IUI, or IVF? Reprod Biomed Online. 2009;19(Suppl 4):4334.PubMed
37.
go back to reference Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012;9:CD001838.PubMed Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012;9:CD001838.PubMed
38.
go back to reference Ferrara I, Balet R, Grudzinskas JG. Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime, Hum Reprod. 2002;17:2320–4.PubMed Ferrara I, Balet R, Grudzinskas JG. Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime, Hum Reprod. 2002;17:2320–4.PubMed
39.
go back to reference Belloc S, Cohen-Bacrie P, Benkhalifa M, Cohen-Bacrie M, De Mouzon J, Hazout A, Menezo Y. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online. 2008;17:392–7.CrossRefPubMed Belloc S, Cohen-Bacrie P, Benkhalifa M, Cohen-Bacrie M, De Mouzon J, Hazout A, Menezo Y. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online. 2008;17:392–7.CrossRefPubMed
40.
go back to reference W.s. National Collaborating Centre for, H. Children’s, National Institute for Health and Clinical Excellence: Guidance, Fertility: Assessment and Treatment for People with Fertility Problems, Royal College of Obstetricians and Gynaecologists National Collaborating Centre for Women’s and Children’s Health, London, 2013. W.s. National Collaborating Centre for, H. Children’s, National Institute for Health and Clinical Excellence: Guidance, Fertility: Assessment and Treatment for People with Fertility Problems, Royal College of Obstetricians and Gynaecologists National Collaborating Centre for Women’s and Children’s Health, London, 2013.
41.
go back to reference Practice M. Committee of the American Society for Reproductive. Use of clomiphene citrate in infertile women: a committee opinion, Fertil Steril. 2013;100:341–8. Practice M. Committee of the American Society for Reproductive. Use of clomiphene citrate in infertile women: a committee opinion, Fertil Steril. 2013;100:341–8.
Metadata
Title
Predicting suitable timing for artificial reproductive technology treatment in aged infertile women
Authors
Nana Akino
Wataru Isono
Osamu Wada-Hiraike
Publication date
01-10-2016
Publisher
Springer Japan
Published in
Reproductive Medicine and Biology / Issue 4/2016
Print ISSN: 1445-5781
Electronic ISSN: 1447-0578
DOI
https://doi.org/10.1007/s12522-016-0241-0

Other articles of this Issue 4/2016

Reproductive Medicine and Biology 4/2016 Go to the issue

Acknowledgments

Acknowledgments